Corbus Pharmaceuticals Receives Anabasum Patent for Inflammatory, Fibrotic Diseases
Corbus Pharmaceuticals recently announced that the U.S. Patent and Trademark Office has issued a patent for the use of anabasum, the company’s lead therapy candidate for the treatment of inflammatory and fibrotic diseases. Read more >>